Back

Evaluation of bleeding events in a cohort of patients with transthyretin cardiac amyloidosis

2 September 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Left ventricular hypertrophy and hypertrophic cardiomyopathy: new findings Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Lucia Moreno De Redrojo Cortes

University Hospital of Salamanca, Salamanca (Spain)

7 More presentations in this session

Presentation thumbnail
Mildly elevated left ventricular outflow tract gradients are associated with increased short term mortality in inpatients without septal hypertrophy
Doctor S. Khoury (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Endomyocardial biopsy in the diagnosis of cardiac sarcoidosis
Ms H. Malkonen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Health-related quality of life disparity in cardiac sarcoidosis versus other myocardial diseases
Mrs J. Raak-Tarkiainen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Health-related quality of life and prognosis in cardiac sarcoidosis
Mrs J. Raak-Tarkiainen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Prevalence of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: the RETTRACE Study
Doctor D. Tsilakis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Left ventricular hypertrophy and hypertrophic cardiomyopathy: new findings

The Event

Event poster

ESC Congress 2024

2 September 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Validation of two simple scores to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Incidence of death and thromboembolic events in patients with light chains and transthyretin cardiac amyloidosis: data from an institutional registry
thumbnail
Congress Presentation
Direct oral anticoagulants versus warfarin for atrial fibrillation in patients with transthyretin cardiac amyloidosis: a retrospective cohort analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources